At a glance
- Originator Banyu
- Class Antineoplastics; Small molecules
- Mechanism of Action Thioredoxin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 19 May 2001 Discontinued-Preclinical for Cancer in Japan (Unknown route)
- 09 Sep 1998 Profile reviewed
- 09 Sep 1998 No-Development-Reported for Cancer in Japan (Unknown route)